Burning mouth syndrome (BMS) is a chronic pain disorder characterized by persistent burning, stinging, or abnormal sensations in the oral mucosa, often in the absence of visible clinical lesions. Its etiology remains unclear, although it has been associated with neuropathic changes and psychological factors. The global prevalence is approximately 1.73%, with higher rates noted in women and individuals over 50 years of age. Due to the limited understanding of this condition, BMS is frequently under- or misdiagnosed as other conditions, such as candidiasis or gastroesophageal reflux disease. Although numerous treatment options have been proposed, most lack strong evidence. Management typically requires personalized combination therapy, including anticonvulsants, anxiolytics, antidepressants, and low-level laser therapy.
This article reports a case of a 61-year-old female patient who presented with tongue tip and palatal pain lasting three months, accompanied by severe depressive symptoms. Laboratory tests ruled out other systemic diseases, and the final diagnosis was BMS with concurrent severe depression and candidiasis. Following initial medication combined with low-level laser therapy, her symptoms improved significantly: pain intensity decreased from severe to mild with intermittent episodes, and depressive mood lessened.
This case highlights the clinical challenges in diagnosing and treating BMS, emphasizing the need for physicians to remain vigilant when encountering patients with persistent oral pain without obvious lesions. Identifying potential comorbidities and employing a combination of pharmacological and non-pharmacological therapies can improve treatment outcomes, thereby enhancing the patient’s quality of life.